Searchable abstracts of presentations at key conferences in endocrinology

ea0008p55 | Growth and development | SFE2004

Intermittent recombinant growth hormone (Saizen) treatment in short children born small for gestational age: Results of two different treatment regimens on growth parameters after 4 years

Simon D , Fjellestad-Paulsen A , Crabbe R , Czernichow P

While a number of studies have shown that treatment of children born small for gestational age (SGA) with continuously administered growth hormone (GH) induces a significant height improvement, this clinical trial approved by the local ethics committee investigated in a prospective way the growth response to different intermittent recombinant human GH (r-hGH, Saizen) treatment regimens over 4 years.Fifty-eight severely short (height standard deviation sc...

ea0008go8 | (1) | SFE2004

Intermittent recombinant growth hormone (Saizen) treatment in short children born small for gestational age: Results of two different treatment regimens on growth parameters after 4 years

Simon D , Fjellesatd-Paulsen A , Crabbe R , Czernichow P

While a number of studies have shown that treatment of children born small for gestational age (SGA) with continuously administered growth hormone (GH) induces a significant height improvement, this clinical trial approved by the local ethics committee investigated in a prospective way the growth response to different intermittent recombinant human GH (r-hGH, Saizen) treatment regimens over 4 years.Fifty-eight severely short (height standard deviation sc...